Alpha Teknova Inc (TKNO) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Alpha Teknova Inc (TKNO) has a cash flow conversion efficiency ratio of -0.052x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.36 Million) by net assets ($64.92 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Alpha Teknova Inc's balance sheet to measure how much of total assets are equity-financed.
Alpha Teknova Inc - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Alpha Teknova Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Alpha Teknova Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Alpha Teknova Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Alpha Teknova Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Imexpharm Corp
VN:IMP
|
0.044x |
|
Grupo Minsa S.A.B. de C.V
MX:MINSAB
|
0.009x |
|
Samara Asset Group
F:SRAG
|
N/A |
|
Firich Enterprises Co Ltd
TWO:8076
|
0.015x |
|
MK Electron Co. Ltd
KQ:033160
|
-0.039x |
|
Circio Holding ASA
OL:CRNA
|
2.054x |
|
Pyrophyte Acquisition Corp. II
NYSE:PAII
|
-0.002x |
|
Vendome Acquisition Corporation I Class A Ordinary Shares
NASDAQ:VNME
|
-0.289x |
Annual Cash Flow Conversion Efficiency for Alpha Teknova Inc (2019–2025)
The table below shows the annual cash flow conversion efficiency of Alpha Teknova Inc from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Alpha Teknova Inc.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $68.78 Million | $-8.65 Million | -0.126x | +16.41% |
| 2024-12-31 | $82.39 Million | $-12.39 Million | -0.150x | +28.03% |
| 2023-12-31 | $90.04 Million | $-18.81 Million | -0.209x | +23.82% |
| 2022-12-31 | $99.89 Million | $-27.40 Million | -0.274x | -333.15% |
| 2021-12-31 | $143.20 Million | $-9.07 Million | -0.063x | -232.49% |
| 2020-12-31 | $52.41 Million | $2.50 Million | 0.048x | -71.59% |
| 2019-12-31 | $12.91 Million | $2.17 Million | 0.168x | -- |
About Alpha Teknova Inc
Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion; and molecular biology reagents for sam… Read more